Research and Development

Researchers at the Great Ormond Street Hospital have published the successful treatment of two infants suffering from leukaemia by treatment …

Takeda UK has appointed Peter Wheatley Price to the role of market access director, where he will also sit on …

Roche’s Tecentriq (atezolizumab) has scored another positive opinion, this time from the Medicines and Healthcare products Regulatory Agency (MHRA), which …

New research, conducted at the University of Kansas, has emerged that reveal a potential use for statins beyond their current …

New research conducted at Washington University’s School of Medicine and published in Cell Reports details a new method for fighting …

Research led by Liverpool University and funded by Cancer Research UK has shown that a combination treatment of two off-patent …

Hetero Labs, an Indian pharmaceutical firm, has been observed by the FDA shredding what the FDA judged to be controlled …

Inside this issue…

AbbVie has announced that its investigational, pan-genotypic regimen of Glecaprevir/Pibrentasvir has been awarded Accelerated Assessment by the European Medicines Agency …

The potential solutions offered by ‘big data’ seems to offer a vision of the future but potential solutions aren’t enough …

A new study has estimated that one in four men could avoid unnecessary invasive biopsies to detect prostate cancer – …

Johnson & Johnson’s Imbruvica (ibrutinib) has scored its fifth indication approval in the US for the treatment of Marginal Zone …

It’s Friday, and there have been some big revelations for the pharma industry this week. Brexit, the ever-present hot topic …

Since their introduction in the UK in 2000, R&D tax credits have provided a significant boost to pharmaceutical and biotech …

Sanofi’s diabetes drug Suliqua has been granted marketing authorisation by the European Commission, giving the go ahead for the launch …